Breaking: Congress nears deal to rein in PBMs

It'd be a victory in the yearslong quest to reform industry middlemen

Log In    Subscribe EXCLUSIVE   Congress nears deal to rein in PBMs after years of debate By Rachel Cohrs Zhang Stefani Reynolds/Getty Images Lawmakers have nearly reached a deal to extend telehealth flexibilities, fund public health programs, bolster physician pay, and enact major pharmacy benefit manager legislation as part of a government funding package that Congress plans to pass before the end of the year, according to sources familiar with the legislation.   The PBM legislation is the culmination of years of debate in Congress, and millions in advertising by the pharmaceutical industry urging more PBM regulation. Until now, PBMs have dodged efforts by federal lawmakers to rein in their practices. READ MORE Sign up for D.C. Diagnosis U.S. politics — and its impact on health care — changes every day. Cut through the noise with our twice-weekly newsletter covering politics and policy. Learn more. In Case You Missed It 1   Exclusive: The pharma industry isn't lobbying against RFK Jr.'s nomination for a top health role By Rachel Cohrs Zhang and John Wilkerson 2   'Tough love': How RFK Jr.'s views on addiction could bring a new era of U.S. drug policy By Lev Facher 3   Biden officials take credit for 'largest drop' in overdose deaths. Experts are more cautious By Lev Facher 4   Ionis blazed trails in genetic medicine. On the cusp of a major approval, can it also be a commercial success? By Jonathan Wosen and Matthew Herper Don't miss out on another STAT Investigation Unlock the world of health and medicine with a subscription to STAT+ Learn more STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us